Comparative efficiency of the preparation "Nodinorm" in complex treatment of fibrocystic mastopathy

AbstractThe pathology of the mammary gland is represented by such diseases as acute and chronic mastitis, fibrocystic mastopathy, gynecomastia, benign and malignant neoplasms, among which the greatest danger is cancer. Among nosological units, fibrocystic mastopathy occupies a special place, which, according to various authors, affects from 50 to 90% of women. Most often, women are sick at the age of 40–50 years. These changes in breast tissue are benign, but patients with mastopathy are at high risk of cancer [3]. A possible solution to the problem of treating patients with combined pathology of the uterus and mammary glands is the use of the domestic drug "Nodinorm" in the complex treatment of the main substance, which is indole-3-carbinol.

Перевод пока недоступен